The Effects of Transdermal Nicotine for the Treatment of Hispanic Smokers

Scott J. Leischow, Anabel Hill, Gretchen Cook

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Objective: To assess the efficacy of transdermal nicotine as an adjunct to smoking cessation in Hispanics. Design: Randomized, double-blind, placebo-controlled pilot clinical trial. Intervention: Nicotine or placebo transdermal system (patch) and brief individual motivational support. Results: Six-week abstinence rates in the nicotine versus placebo groups were 63 versus 35%, respectively, and were 46 versus 26%, respectively, at 10 weeks. These differences in abstinence rates between the two groups were significant at 6 weeks (x2 = 7.26, p <0.01) and 10 weeks (x2 = 4.01, p = 0.05). Withdrawal symptoms were not suppressed, though weight was suppressed, in the transdermal nicotine group.

Original languageEnglish (US)
Pages (from-to)304-311
Number of pages8
JournalAmerican Journal of Health Behavior
Volume20
Issue number5
StatePublished - 1996
Externally publishedYes

Fingerprint

Nicotine
Hispanic Americans
nicotine
Placebos
Transdermal Patch
Substance Withdrawal Syndrome
Group
Controlled Clinical Trials
Smoking Cessation
Therapeutics
withdrawal
smoking
Weights and Measures

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health
  • Leadership and Management

Cite this

The Effects of Transdermal Nicotine for the Treatment of Hispanic Smokers. / Leischow, Scott J.; Hill, Anabel; Cook, Gretchen.

In: American Journal of Health Behavior, Vol. 20, No. 5, 1996, p. 304-311.

Research output: Contribution to journalArticle

Leischow, SJ, Hill, A & Cook, G 1996, 'The Effects of Transdermal Nicotine for the Treatment of Hispanic Smokers', American Journal of Health Behavior, vol. 20, no. 5, pp. 304-311.
Leischow, Scott J. ; Hill, Anabel ; Cook, Gretchen. / The Effects of Transdermal Nicotine for the Treatment of Hispanic Smokers. In: American Journal of Health Behavior. 1996 ; Vol. 20, No. 5. pp. 304-311.
@article{5da4e1c65a944164bf4c73d96980d984,
title = "The Effects of Transdermal Nicotine for the Treatment of Hispanic Smokers",
abstract = "Objective: To assess the efficacy of transdermal nicotine as an adjunct to smoking cessation in Hispanics. Design: Randomized, double-blind, placebo-controlled pilot clinical trial. Intervention: Nicotine or placebo transdermal system (patch) and brief individual motivational support. Results: Six-week abstinence rates in the nicotine versus placebo groups were 63 versus 35{\%}, respectively, and were 46 versus 26{\%}, respectively, at 10 weeks. These differences in abstinence rates between the two groups were significant at 6 weeks (x2 = 7.26, p <0.01) and 10 weeks (x2 = 4.01, p = 0.05). Withdrawal symptoms were not suppressed, though weight was suppressed, in the transdermal nicotine group.",
author = "Leischow, {Scott J.} and Anabel Hill and Gretchen Cook",
year = "1996",
language = "English (US)",
volume = "20",
pages = "304--311",
journal = "American Journal of Health Behavior",
issn = "1087-3244",
publisher = "PNG Publications",
number = "5",

}

TY - JOUR

T1 - The Effects of Transdermal Nicotine for the Treatment of Hispanic Smokers

AU - Leischow, Scott J.

AU - Hill, Anabel

AU - Cook, Gretchen

PY - 1996

Y1 - 1996

N2 - Objective: To assess the efficacy of transdermal nicotine as an adjunct to smoking cessation in Hispanics. Design: Randomized, double-blind, placebo-controlled pilot clinical trial. Intervention: Nicotine or placebo transdermal system (patch) and brief individual motivational support. Results: Six-week abstinence rates in the nicotine versus placebo groups were 63 versus 35%, respectively, and were 46 versus 26%, respectively, at 10 weeks. These differences in abstinence rates between the two groups were significant at 6 weeks (x2 = 7.26, p <0.01) and 10 weeks (x2 = 4.01, p = 0.05). Withdrawal symptoms were not suppressed, though weight was suppressed, in the transdermal nicotine group.

AB - Objective: To assess the efficacy of transdermal nicotine as an adjunct to smoking cessation in Hispanics. Design: Randomized, double-blind, placebo-controlled pilot clinical trial. Intervention: Nicotine or placebo transdermal system (patch) and brief individual motivational support. Results: Six-week abstinence rates in the nicotine versus placebo groups were 63 versus 35%, respectively, and were 46 versus 26%, respectively, at 10 weeks. These differences in abstinence rates between the two groups were significant at 6 weeks (x2 = 7.26, p <0.01) and 10 weeks (x2 = 4.01, p = 0.05). Withdrawal symptoms were not suppressed, though weight was suppressed, in the transdermal nicotine group.

UR - http://www.scopus.com/inward/record.url?scp=0030518737&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030518737&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0030518737

VL - 20

SP - 304

EP - 311

JO - American Journal of Health Behavior

JF - American Journal of Health Behavior

SN - 1087-3244

IS - 5

ER -